Navigation Links
PharmAthene Presents Data for Protexia(R) and Valortim(R) at 2008 BARDA Industry Conference / PHEMCE Stakeholders Workshop
Date:9/24/2008

reated with non-pegylated rBChE supports the conclusions of an earlier study (Mikler et al, 2007) that rBChE has potential utility as a post poisoning therapy. The investigators suggest that the data provide the first tangible evidence of the predicted mechanisms of post poisoning intervention with rBChE.

"The majority of our research to date for Protexia(R) has focused on studying its efficacy as a pre-exposure prophylactic. The promising preliminary data are particularly encouraging as they demonstrate that the non-pegylated rBChE may also be efficacious as a therapeutic for nerve agents. We plan to undertake further confirmatory work with Protexia(R) to build upon these exciting preliminary observations," said Mr. Wright.

Valortim(R) Findings Reported

In a poster entitled, "Efficacy of Intravenous Valortim(R), an Anti-toxin Monoclonal Antibody, in the Treatment of Inhalation Anthrax in the African Green Monkey Model," investigators at USAMRIID sought to refine the AGM as a therapeutic model by assessing the efficacy of an anti-toxin monoclonal antibody. In the study, 21 adult AGMs were exposed by aerosol to Ames anthrax spores and blood samples were collected every 4-8 hours beginning 24-hours post exposure to assess anthrax bacteremia and protective antigen in blood. Samples were analyzed for protective antigen via a rapid electrochemiluminescent immunoassay (ECL) and bacteremia was evaluated by 24-hour culture. In the study, 6 AGMs were treated with one intravenous dose of 10 mg/kg Valortim(R) when positive by ECL; a second cohort of 6 AGMs was treated with 2 intravenous doses of 10 mg/kg Valortim(R) (the first given when positive by ECL and the second dose administered 24 hours later), and a third cohort of 6 AGMs was treated with one intravenous dose of 20 mg/kg Valortim(R) when positive by ECL.

Results showed that 56% (10 of 18) of the Valortim(R)-treated animals survived while all saline-treated controls (3) succumbed to inhalati
'/>"/>

SOURCE PharmAthene, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. PharmAthene to Webcast its Third Quarter Conference Call on November 13, 2007 at 4:30 P.M. Eastern Time
2. PharmAthenes Recombinant Butyrylcholinesterase (rBChE) May Play A Neuroprotective Role in Alzheimers Disease
3. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
4. EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer
5. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
6. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
7. CEL-SCI Presents Data for CEL-1000 as a Vaccine Adjuvant with Recombinant Hepatitis B Virus Protein
8. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
9. Targanta Presents First Data Demonstrating In Vitro Activity and In Vivo Efficacy of Prodrugs in Osteomyelitis Models
10. Wyeth Presents Phase 3 Fracture Data for Bazedoxifene, an Investigational Therapy for Osteoporosis
11. Aegerion Pharmaceuticals, Inc. Presents Final Results of Phase II Clinical Trials for AEGR-733 at Drugs Affecting Lipid Metabolism (DALM) 2007 Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... , Nov. 21, 2014  PTC Therapeutics, Inc. (NASDAQ: ... 2014 Legend of Technology Award for Vision, Innovation, and Leadership ... Chief Executive Officer. This award recognizes an individual who has ... New Jersey for several decades. ... Award," stated Stuart Peltz , Ph.D., CEO of PTC ...
(Date:11/21/2014)... YORK , Nov. 20, 2014  Market research firm ... the "Year of The Buy, in the medical device ... for medical devices will produce just 3% growth this ... actions, including acquisitions of product lines and entrance by ... annual survey of medical devices, The Global Market ...
(Date:11/21/2014)... -- Michael DeMarco (42) erinnert sich kaum ... 2014 zugetragen hat. Seine Tochter Aly Demarco (13) wird ... - http://youtu.be/5cVoMCe0uiE „Man hat ... zu machen", erzählt Michael DeMarco . „Meine Frau ... Anhänger der CrossFit-Trainingsmethode. Ich war auf dem Fahrrad, stand ...
Breaking Medicine Technology:PTC Therapeutics Announces CEO, Dr. Stuart Peltz Recipient of The New Jersey Technology Council's 2014 Legend of Technology Award 2PTC Therapeutics Announces CEO, Dr. Stuart Peltz Recipient of The New Jersey Technology Council's 2014 Legend of Technology Award 3Kalorama: 2014 The "Year of The Buy" in Medical Device Industry 2Tochter rettet Vater durch Herz-Lungen-Wiederbelebung vor plötzlichem Herztod 2Tochter rettet Vater durch Herz-Lungen-Wiederbelebung vor plötzlichem Herztod 3
... BEDFORD, Mass., April 4, 2011 Hologic, Inc. (Hologic ... leading developer, manufacturer and supplier of premium diagnostics, medical ... healthcare needs of women, today announced plans to release ... May 2, 2011 after market close. In conjunction with the ...
... CINCINNATI, April 4, 2011 CarePoint ... Infusion Association Annual Conference in Orlando, Florida that ... home infusion therapies including antibiotics, IVIG, nutrition, the ... injections, with locations in North Miami and Tampa. ...
Cached Medicine Technology:Hologic to Release Second Quarter Fiscal 2011 Operating Results on Monday, May 2, 2011 2CarePoint Partners Expands Florida Footprint With Acquisition of Infusion Technologies 2
(Date:11/23/2014)... Dallas, TX (PRWEB) November 23, 2014 ... Energy Devices Market 2006 to 2020 - Asia-Pacific” ... and energy devices market segments: minimally invasive body ... resurfacing devices. The analysis includes market size data ... period for the following countries: China, Japan, South ...
(Date:11/23/2014)... holidays can be a challenge for families of children ... an expert says. "Holidays with family can be ... have children with special needs, some care must be ... of the Sciences in Philadelphia, said in a university ... or visitors know what special requirements are needed to ...
(Date:11/23/2014)... November 23, 2014 More than two ... in a federal litigation involving Byetta lawsuits ( http://www.byettalawsuit2013.com/ ... Bernstein Liebhard LLP reports. , A Case List ... a class of Type 2 diabetes medications referred to ... U.S. District Court, Southern District of California, where a ...
(Date:11/23/2014)... (PRWEB) November 23, 2014 Syngenta lawsuits ... on behalf of farmers and agribusinesses that have allegedly ... to commercialize Agrisure Viptera and Agrisure Duracade, genetically ... been approved for sale in China. According to a ... to virtually ban U.S. corn imports. Because China is ...
(Date:11/22/2014)... A new AlignLife Chiropractic & Natural Health Center ... area. Dr. Chelsea Sineath, owner and chiropractor at ... own clinic after working in another AlignLife office and ... AlignLife believes that the body can heal itself when ... care and rehabilitation to allow the spine to maintain ...
Breaking Medicine News(10 mins):Health News:Aesthetic Lasers and Energy Devices Market in APAC (China, Japan, South Korea, Australia and India) to 2020 2Health News:Aesthetic Lasers and Energy Devices Market in APAC (China, Japan, South Korea, Australia and India) to 2020 3Health News:Aesthetic Lasers and Energy Devices Market in APAC (China, Japan, South Korea, Australia and India) to 2020 4Health News:Holidays Can Be Sensory Overload for Kids With Autism 2Health News:California Federal Court Overseeing Byetta Lawsuits, Other Incretin Mimetic Claims Adds New Cases in November, Bernstein Liebhard LLP Reports 2Health News:California Federal Court Overseeing Byetta Lawsuits, Other Incretin Mimetic Claims Adds New Cases in November, Bernstein Liebhard LLP Reports 3Health News:California Federal Court Overseeing Byetta Lawsuits, Other Incretin Mimetic Claims Adds New Cases in November, Bernstein Liebhard LLP Reports 4Health News:Syngenta Lawsuits Being Investigated by Wright & Schulte LLC, Following China’s Rejection of Corn Shipments Tainted with Unapproved GMO Seed 2Health News:Syngenta Lawsuits Being Investigated by Wright & Schulte LLC, Following China’s Rejection of Corn Shipments Tainted with Unapproved GMO Seed 3Health News:AlignLife of Downtown Greenville is Now Open and Accepting New Patients 2
... Nov. 28 NanoLogix, Inc. (OTC:,NNLX - ... company has,submitted international patent applications for BioNanoChannel(TM) ... Brazil, and the,EU (European Union). These filings ... of the company,s BioNanoChannel(TM) rapid,bacteria/microorganism detection technology ...
... Antonio, TX -, ORANGEBURG, N.Y., Nov. 28 ... a national diabetes clinical,trial of its TANTALUS(R) System, an ... who are overweight. The study is being,conducted in up ... 300-patient trial will evaluate the TANTALUS, an implantable device,that ...
... experts has published the first comprehensive review of evidence ... infection. Now available in the on-line edition of the ... increases the risk of pneumococcal infection by up to ... serotypes in the PCV, and that the vaccine can ...
... California San Diego have developed a novel computer technique ... The study, reported November 30 in PLoS Computational Biology ... Estrogen Receptor Modulators (SERMs), which includes tamoxifen, the most ... Unexpected side effects account for one-third of all drug ...
... Bailey Becomes President of International Operations, MONROVIA, ... STAA ), a leading developer, manufacturer and marketer ... G.,Caldwell, (57) has been named President and Chief ... Directors at the annual shareholder,s,meeting in May 2007, ...
... MINNEAPOLIS, Nov. 28 Novant Health(R) today ... industry leader,in developing and manufacturing medical devices ... will implement the Cardiocom System in its,Presbyterian ... Carolina.,Presbyterian Hospital is one of the largest ...
Cached Medicine News:Health News:NanoLogix Inc. Files Multiple International Patent Applications for BioNanoChannel(TM) and Hydrogen Bioreactor Technology 2Health News:MetaCure(TM) Launches Investigational Study of Gastric Stimulator for Patients With Type 2 Diabetes Who are Overweight 2Health News:Pneumococcal conjugate vaccines can improve the lives of HIV-infected children 2Health News:Barry G. Caldwell Named Chief Executive Officer of STAAR Surgical 2Health News:Barry G. Caldwell Named Chief Executive Officer of STAAR Surgical 3Health News:Barry G. Caldwell Named Chief Executive Officer of STAAR Surgical 4Health News:Barry G. Caldwell Named Chief Executive Officer of STAAR Surgical 5Health News:Barry G. Caldwell Named Chief Executive Officer of STAAR Surgical 6Health News:Novant Health(R) Selects Cardiocom(R) to Provide Telemonitoring for Presbyterian Hospital Heart Failure Program 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: